BUSINESSBLOOMBERG
AstraZeneca Is Said to Have Explored Bristol Myers Merger
AstraZeneca has explored an acquisition of Bristol Myers Squibb, though it is unclear if discussions are ongoing or will result in a transaction. AstraZeneca declined to comment, and Bristol Myers Squibb could not be reached for comment.
Mentioned
Related Signal
Adjacent reporting
- AstraZeneca Said to Have Explored Bristol Myers Merger
- AstraZeneca said to have explored Bristol Myers merger
- AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
- FirstFT: AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up
- AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
- Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration